Psychological intervention on COVID-19 A protocol for systematic review and meta-analysis

被引:15
|
作者
Gu Renjun [1 ]
Li Ziyun [2 ]
Yan Xiwu [1 ]
Wei Wei [1 ]
Gu Yihuang [3 ]
Zhang Chunbing [4 ]
Sun Zhiguang [5 ]
机构
[1] Nanjing Univ Chinese Med, Sch Clin Med 1, Nanjing, Jiangsu, Peoples R China
[2] Nanjing Univ Chinese Med, Sch Clin Med 3, Nanjing, Jiangsu, Peoples R China
[3] Nanjing Univ Chinese Med, Acupuncture & Tuina Sch, Nanjing, Jiangsu, Peoples R China
[4] Jiangsu Prov Hosp Chinese Med, Nanjing 210023, Jiangsu, Peoples R China
[5] Nanjing Univ Chinese Med, Sch Clin Med 2, Nanjing, Jiangsu, Peoples R China
关键词
COVID-19; meta-analysis; psychological intervention; systematic review;
D O I
10.1097/MD.0000000000020335
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: COVID-19 is novel coronavirus infection in 2019. Many reports suggested that psychological intervention is playing a positive role in COVID-19 treatment, but there is no high-quality evidence to prove its effects. This paper reports the protocol of a systematic review and meta-analysis to clarify effectiveness of psychological intervention during the treatment of COVID-19. Methods and analysis: The following electronic databases will be used by 2 independent reviewers: Web of Science, Embase, Cochrane Library, PubMed, Chinese Biomedical Literature Database, Chinese National Knowledge Infrastructure, Chinese Scientific Journal Database, Wan fang Database, ClinicalTrials, WHO Trials, and Chinese Clinical Trial Registry. The randomised controlled trials of psychological intervention on COVID-19 will be searched in the databases by 2 researchers independently. Clinical recovery time and effective rate will be assessed as the primary outcomes. Changes of patients physical condition (1. Time until COVID-19 RT-PCR negative in upper respiratory tract specimen; 2. Time until cough reported as mild or absent; 3. Time until dyspnea reported as mild or absent; 4. Frequency of requiring supplemental oxygen or non-invasive ventilation; 5. Frequency of requiring respiratory; 6. Incidence of severe cases; 7. Proportion of re-hospitalization or admission to ICU; 8. All-cause mortality; 9. Frequency of seriously adverse events) and changes of psychological condition (such as: SRQ-20, PHQ-9, GAD-7, Hamilton Depression Scale, Hamilton Anxiety Scale) will be assessed as the secondary outcomes. For dichotomous outcomes, such as effective rate, data will be expressed as risk ratio (RR) with 95% confidence intervals (CIs). For continuous outcomes, weighted mean differences (WMD) or standardized mean differences (SMD) will be calculated. Fixed effect model will be used for evaluating efficiency. Considering clinical heterogeneity, random effect model will be used for continuous outcomes. Results: Relevant studies will be used to evaluate whether psychological intervention is effective for COVID-19. Conclusion: This study will provide reliable evidence for psychological intervention on COVID-19. PROSPERO registration number: CRD42020178699
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Clinical symptoms of COVID-19 pneumonia in children A protocol for systematic review and meta-analysis
    Tang, Zhengwu
    Li, Muzhe
    Chen, Wei
    Ran, Xun
    Li, Huiyun
    Chen, Zhiwei
    MEDICINE, 2021, 100 (01) : E24108
  • [32] Global prevalence of physical and psychological child abuse during COVID-19: A systematic review and meta-analysis
    Lee, Hyun
    Kim, EunKyung
    CHILD ABUSE & NEGLECT, 2023, 135
  • [33] Smell disorders in COVID-19 patients: role of olfactory training A protocol for systematic review and meta-analysis
    Zhang, Yu
    Mei, Tao
    Chen, Ying
    Wang, Lina
    Jiang, Lulian
    Liu, Ke
    Zhao, Liping
    Luo, Ziyu
    Chi, Wenxin
    Zhu, Xiangyu
    MEDICINE, 2021, 100 (08) : E24862
  • [34] The relationship between hyperglycemia and the infection of COVID-19 in diabetic patients A protocol for systematic review and meta-analysis
    Liu, Yan
    Yang, Yan
    Chen, Yalin
    Zhou, Linyue
    Xiong, Qian
    Xie, Chunguang
    MEDICINE, 2020, 99 (36)
  • [35] Mortality of Patients With Candidemia and COVID-19: A Systematic Review With Meta-analysis
    Colaneri, Marta
    Giusti, Emanuele Maria
    Genovese, Camilla
    Galli, Lucia
    Lombardi, Andrea
    Gori, Andrea
    OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (07):
  • [36] Remdesivir for treatment of COVID-19; an updated systematic review and meta-analysis
    Rezagholizadeh, Afra
    Khiali, Sajad
    Sarbakhsh, Parvin
    Entezari-Maleki, Taher
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 897
  • [37] Prognosis of COVID-19 in patients with breast cancer A protocol for systematic review and meta-analysis
    Sheng, Zhijuan
    Zhang, Li
    Liu, Xinlu
    Yuan, Li
    Li, Fei
    Dai, Dingmei
    Wu, Shuilin
    Yang, Jingzhi
    MEDICINE, 2020, 99 (31)
  • [38] A systematic review and meta-analysis of the epidemiological characteristics of COVID-19 in children
    Vosoughi, Fardis
    Makuku, Rangarirai
    Tantuoyir, Marcarious M.
    Yousefi, Farbod
    Shobeiri, Parnian
    Karimi, Amirali
    Alilou, Sanam
    LaPorte, Ronald
    Tilves, Curtis
    Nabian, Mohammad Hossein
    Yekaninejad, Mir Saeed
    BMC PEDIATRICS, 2022, 22 (01)
  • [39] COVID-19 and Parkinson's disease: a systematic review and meta-analysis
    Afraie, Maryam
    Moradi, Ghobad
    Mohammadzedeh, Pardis
    Azami, Mobin
    Riyahifar, Sevda
    Moradi, Yousef
    ACTA NEUROLOGICA BELGICA, 2023, 123 (04) : 1209 - 1223
  • [40] Accuracy of serological tests for COVID-19: A systematic review and meta-analysis
    Zheng, Xiaoyan
    Duan, Rui hua
    Gong, Fen
    Wei, Xiaojing
    Dong, Yu
    Chen, Rouhao
    Yue Liang, Ming
    Tang, Chunzhi
    Lu, Liming
    FRONTIERS IN PUBLIC HEALTH, 2022, 10